182 related articles for article (PubMed ID: 25527419)
41. The effects of some nonsteroidal anti-inflammatory drugs on experimental induced gastric ulcers in rats.
Batu OS; Erol K
Inflammopharmacology; 2007 Dec; 15(6):260-5. PubMed ID: 18236017
[TBL] [Abstract][Full Text] [Related]
42. Beta-carotene inhibits Helicobacter pylori-induced expression of inducible nitric oxide synthase and cyclooxygenase-2 in human gastric epithelial AGS cells.
Jang SH; Lim JW; Kim H
J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():131-7. PubMed ID: 20388956
[TBL] [Abstract][Full Text] [Related]
43. Transactivation of the EGFR by AP-1 is induced by Helicobacter pylori in gastric cancer.
Ashktorab H; Daremipouran M; Wilson M; Siddiqi S; Lee EL; Rakhshani N; Malekzadeh R; Johnson AC; Hewitt SM; Smoot DT
Am J Gastroenterol; 2007 Oct; 102(10):2135-46. PubMed ID: 17617207
[TBL] [Abstract][Full Text] [Related]
44. [Inhibitory effects of celecoxib combined with octreotide on growth of multidrug resistant human gastric cancer cell line SGC7901/ADR].
Zheng WB; Wang CH; Qiang O; Tang CW
Ai Zheng; 2004 Dec; 23(12):1628-32. PubMed ID: 15601550
[TBL] [Abstract][Full Text] [Related]
45. Serum and gastric fluid levels of cytokines and nitrates in gastric diseases infected with Helicobacter pylori.
Mehmet N; Refik M; Harputluoglu M; Ersoy Y; Aydin NE; Yildirim B
New Microbiol; 2004 Apr; 27(2):139-48. PubMed ID: 15164624
[TBL] [Abstract][Full Text] [Related]
46. Expression of cyclooxygenase-2 in primary and remnant gastric carcinoma: comparing it with p53 accumulation, Helicobacter pylori infection, and vascular endothelial growth factor expression.
Kawabe A; Shimada Y; Uchida S; Maeda M; Yamasaki S; Kato M; Hashimoto Y; Ohshio G; Matsumoto M; Imamura M
J Surg Oncol; 2002 Jun; 80(2):79-88. PubMed ID: 12173384
[TBL] [Abstract][Full Text] [Related]
47. Dietary prevention of Helicobacter pylori-associated gastric cancer with kimchi.
Jeong M; Park JM; Han YM; Park KY; Lee DH; Yoo JH; Cho JY; Hahm KB
Oncotarget; 2015 Oct; 6(30):29513-26. PubMed ID: 26317548
[TBL] [Abstract][Full Text] [Related]
48. Promoter methylation regulates Helicobacter pylori-stimulated cyclooxygenase-2 expression in gastric epithelial cells.
Akhtar M; Cheng Y; Magno RM; Ashktorab H; Smoot DT; Meltzer SJ; Wilson KT
Cancer Res; 2001 Mar; 61(6):2399-403. PubMed ID: 11289104
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of cyclooxygenase-2 causes regression of gastric adenomas in trefoil factor 1 deficient mice.
Thiel A; Narko K; Heinonen M; Hemmes A; Tomasetto C; Rio MC; Haglund C; Mäkelä TP; Ristimäki A
Int J Cancer; 2012 Sep; 131(5):1032-41. PubMed ID: 22034055
[TBL] [Abstract][Full Text] [Related]
50. [Selective COX-2 inhibitor delays experimental gastric ulcer healing by stimulating gastric acid secretion in rats].
He MR; Lin JQ; Song YG
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):1015-7. PubMed ID: 17666341
[TBL] [Abstract][Full Text] [Related]
51. Selective Cox-2 inhibitor celecoxib induces epithelial-mesenchymal transition in human lung cancer cells via activating MEK-ERK signaling.
Wang ZL; Fan ZQ; Jiang HD; Qu JM
Carcinogenesis; 2013 Mar; 34(3):638-46. PubMed ID: 23172668
[TBL] [Abstract][Full Text] [Related]
52. The effects of cyclooxygenase2-prostaglandinE2 pathway on Helicobacter pylori-induced urokinase-type plasminogen activator system in the gastric cancer cells.
Iwamoto J; Mizokami Y; Takahashi K; Matsuoka T; Matsuzaki Y
Helicobacter; 2008 Jun; 13(3):174-82. PubMed ID: 18466392
[TBL] [Abstract][Full Text] [Related]
53. [Short-term preoperative treatment of celecoxib, a selective cyclooxygenase-2 inhibitor, on E-cadherin expression in gastric carcinoma tissues].
Ran JT; Zhou YN; Tang CW; Li HH; Li XW; Lu H
Ai Zheng; 2009 Apr; 28(4):361-5. PubMed ID: 19622294
[TBL] [Abstract][Full Text] [Related]
54. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
Wang L; Chen W; Xie X; He Y; Bai X
Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
[TBL] [Abstract][Full Text] [Related]
55. Helicobacter pylori enhances cyclooxygenase 2 expression via p38MAPK/ATF-2 signaling pathway in MKN45 cells.
Li Q; Liu N; Shen B; Zhou L; Wang Y; Wang Y; Sun J; Fan Z; Liu RH
Cancer Lett; 2009 Jun; 278(1):97-103. PubMed ID: 19201083
[TBL] [Abstract][Full Text] [Related]
56. Helicobacter pylori induces gastric mucosal intestinal metaplasia through the inhibition of interleukin-4-mediated HMG box protein Sox2 expression.
Asonuma S; Imatani A; Asano N; Oikawa T; Konishi H; Iijima K; Koike T; Ohara S; Shimosegawa T
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G312-22. PubMed ID: 19520737
[TBL] [Abstract][Full Text] [Related]
57. Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: role of COX-2 and MDR-1.
Arunasree KM; Roy KR; Anilkumar K; Aparna A; Reddy GV; Reddanna P
Leuk Res; 2008 Jun; 32(6):855-64. PubMed ID: 18083230
[TBL] [Abstract][Full Text] [Related]
58. Expression of Lewis antigens and their precursors in gastric mucosa: relationship with Helicobacter pylori infection and gastric carcinogenesis.
Lee HS; Choe G; Kim WH; Kim HH; Song J; Park KU
J Pathol; 2006 May; 209(1):88-94. PubMed ID: 16456898
[TBL] [Abstract][Full Text] [Related]
59. Vitamin D₃ upregulated protein 1 deficiency promotes N-methyl-N-nitrosourea and Helicobacter pylori-induced gastric carcinogenesis in mice.
Kwon HJ; Won YS; Nam KT; Yoon YD; Jee H; Yoon WK; Nam KH; Kang JS; Han SU; Choi IP; Kim DY; Kim HC
Gut; 2012 Jan; 61(1):53-63. PubMed ID: 21917648
[TBL] [Abstract][Full Text] [Related]
60. Helicobacter pylori VacA toxin up-regulates vascular endothelial growth factor expression in MKN 28 gastric cells through an epidermal growth factor receptor-, cyclooxygenase-2-dependent mechanism.
Caputo R; Tuccillo C; Manzo BA; Zarrilli R; Tortora G; Blanco Cdel V; Ricci V; Ciardiello F; Romano M
Clin Cancer Res; 2003 Jun; 9(6):2015-21. PubMed ID: 12796363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
